JM SMUCKER CO/THE (SJM)       150.02  -0.06 (-0.04%)

150.02  -0.06 (-0.04%)

US8326964058 - Common Stock - After market: 150.02 0 (0%)


Fundamental Rating

4

Overall SJM gets a fundamental rating of 4 out of 10. We evaluated SJM against 105 industry peers in the Food Products industry. The financial health of SJM is medium. Also its profitability is quite bad. SJM is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

3

SJM's Profit Margin of 7.00% is amongst the best of the industry. SJM does better than the industry average Profit Margin of 5.77%.
The Piotroski-F score of SJM is 6.00. This is a neutral score and indicates average health and profitability for SJM.

SJM's Return On Assets of 3.52% is worse than the rest of the industry. The industry average Return On Assets is 6.01%.
SJM has a Return On Equity of 6.95%. This is below the industry average of 14.51%.
VS Industry

ROA (3.52%) VS Industry: 30% outperformed.

0.13
26.84

ROE (6.95%) VS Industry: 22% outperformed.

0.23
82.65

Profit Margin (7%) VS Industry: 61% outperformed.

0.08
41.73

Valuation

Valuation Rating

3

The Price/Earnings Ratio is 17.38, which indicates a rather expensive current valuation of SJM.
SJM's Price/Earning Ratio is in line with the industry average which is at 21.35.
The Forward Price/Earnings Ratio of 15.39 indicates a correct valuation of SJM.
When comparing the current price to the book value of SJM, we can conclude it is valued correctly. It is trading at 1.95 times its book value.

Compared to an average industry price book ratio of 1.86, SJM is valued in line with its industry peers.
Compared to an average industry Enterprise Value to EBITDA ratio of 14.20, SJM is valued in line with its industry peers.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates SJM does not grow enough to justify the current Price/Earnings ratio.
VS Industry

Price/Earnings (17.38) VS Industry: 60% outperformed.

549.00
0.40

Price/Book (1.95) VS Industry: 47% outperformed.

238.68
0.03

Enterprise Value/ EBITDA (13.19) VS Industry: 55% outperformed.

632.57
0.88

Growth

Growth Rating

5

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
SJM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.46%.
Measured over the past 5 years, SJM shows a small growth in Earnings Per Share. The EPS has been growing by 2.89% on average per year.

The Earnings Per Share is expected to grow by 7.08% on average over the next 5 years.
The Revenue has been growing slightly by 3.34% in the past year.
The Revenue has been growing slightly by 1.59% on average over the past 5 years.
SJM is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 3.05% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS2.89% 2.36% -0.46% -2.32% 4.72% 4.89% 7.08%
Revenue1.59% 0.68% 3.34% 6.46% 4.38% 3.22% 3.05%

Health

Health Rating

4

SJM has a Current Ratio of 1.09. This is a normal value and indicates that SJM is financially healthy and should not expect problems in meeting its short term obligations.
The Debt to Equity ratio of SJM is in line with the industry averages.
SJM has an Altman-Z score of 2.20. This is not the best score and indicates that SJM is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score is in line with the industry averages, which is at 2.20.

The Piotroski-F score of SJM is 6.00. This is a neutral score and indicates average health and profitability for SJM.
Compared to an average industry Current Ratio of 1.80, SJM is worse placed to pay its short term obligations than its industry peers.
SJM has a Quick Ratio of 1.09. This is a bad value and indicates that SJM is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Quick Ratio of SJM to the average industry Current Ratio of 0.88, SJM is less able to pay its short term obligations than its industry peers. 87% of its industry peers have a better Quick Ratio.
VS Industry

Debt/Equity (0.53) VS Industry: 50% outperformed.

53.34
0.00

Quick Ratio (0.43) VS Industry: 13% outperformed.

0.01
37.12

Current Ratio (1.09) VS Industry: 23% outperformed.

0.01
37.46

Altman-Z (2.2) VS Industry: 50% outperformed.

-34.87
72.63

Dividend

Dividend Rating

4

SJM has paid a dividend for at least 10 years, which is a reliable track record.
With a Yearly Dividend Yield of 2.64%, SJM has a reasonable but not impressive dividend return.
SJM's Dividend Yield is comparable with the S&P500 average which is at 2.40.
The dividend of SJM has a limited annual growth rate of 5.14%.

SJM's Dividend Yield is slightly below the industry average, which is at 2.95.
SJM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
74.80% of the earnings are spent on dividend by SJM. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (2.64%) VS Industry: 40% outperformed.

0.80
18.60

JM SMUCKER CO/THE150.02

NYSE:SJM (1/27/2023, 6:37:21 PM)-0.06 (-0.04%)

After market: 150.02 0 (0%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Food Products
Earnings (Last) 11-21 2022-11-21/bmo Earnings (Next) 02-27 2023-02-27
Inst Owners 82.46% Inst Owner Change 2.59%
Ins Owners 1.3% Ins Owner Change -3.13%
Market Cap 16.00B Analysts 51.67
Price Target 152.92 (1.93%)

Dividend
Dividend Yield 2.64% Dividend Growth 5.14%
DP 74.8% Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 19.15%
Min EPS beat(2) 8.35% Max EPS beat(2) 29.96%
EPS beat(4) 4 Avg EPS beat(4) 16.56%
Min EPS beat(4) 8.35% Max EPS beat(4) 29.96%
Revenue beat(2) 1 Avg Revenue beat(2) -0.31%
Min Revenue beat(2) -0.9% Max Revenue beat(2) 0.28%
Revenue beat(4) 2 Avg Revenue beat(4) 0.22%
Min Revenue beat(4) -0.9% Max Revenue beat(4) 1.79%
PT rev (1m) -0.38% EPS NQ rev (1m) -9.29%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 1.59%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 17.38
Fwd PE 15.39
P/S 1.96
P/FCF 30.84
P/OCF 16.01
P/B 1.95
P/tB N/A
EV/EBITDA 13.19
EPS(TTM) 8.63 EY 5.75%
EPS(NY) 9.75 Fwd EY 6.5%
FCF(TTM) 4.86 FCFY 3.24%
OCF(TTM) 9.37 OCFY 6.25%
SpS 76.6 BVpS 77.06
TBVpS -31.2 PEG (NY) N/A
PEG (5Y) 6.02

Profitability
Industry RankSector Rank
ROA 3.52%
ROE 6.95%
ROIC 5.62%
ROICexc 5.63%
ROICexgc 28.11%
OM 13.29%
PM 7%
GM 32.04%
ROICexgc(3y) 57.04% ROICexcg growth 3Y -11.46%
ROICexcg growth 5Y -6.25% ROICexc(3y) 6.9%
ROICexc growth 3Y 2.02% ROICexc growth 5Y -1.09%
OM growth 3Y -0.03% OM growth 5Y -2.61%
PM growth 3Y 6.44% PM growth 5Y -0.25%
GM growth 3Y -2.93% GM growth 5Y -2.41%
F-Score 6 Asset Turnover 0.5

Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 8.9
Debt/EBITDA 3
Cap/Depr 106.19%
Profit Quality 90.76%
Current Ratio 1.09
Quick Ratio 0.43
Altman-Z 2.2
F-Score 6 WACC 7.15%
ROIC/WACC 3.93 Cap/Depr(3y) 73.01%
Cap/Depr(5y) 75.51% Profit Quality(3y) 128.49%
Profit Quality(5y) 121.08%

Growth
EPS 1Y -0.46% EPS 3Y 2.36%
EPS 5Y 2.89% EPS growth Q2Q -1.23%
EPS Next Y -2.32% EPS Next 2Y 4.72%
EPS Next 3Y 4.89% EPS Next 5Y 7.08%
Revenue growth 1Y 3.34% Revenue growth 3Y 0.68%
Revenue growth 5Y 1.59% Revenue growth Q2Q 7.57%
Revenue Next Year 6.46% Revenue Next 2Y 4.38%
Revenue Next 3Y 3.22% Revenue Next 5Y 3.05%
EBIT growth 1Y -13.46% EBIT growth 3Y 0.65%
EBIT growth 5Y -1.06% EBIT Next Year 18.85%
EBIT Next 3Y 9.7% EBIT Next 5Y N/A
FCF growth 1Y -61.15% FCF growth 3Y -2.75%
FCF growth 5Y -3.67% OCF growth 1Y -37.42%
OCF growth 3Y -0.14% OCF growth 5Y 1.42%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA